|
|
 |
 |
| Plasma Volume Replacement (PVR) |
 |
 |
| Water is the dominant substance of the human body. Its water content
depends on age and sex. For a young adult, body water constitutes about
60% of body weight and is distributed between intracellular and extracellular
space in a ratio of about 2 : 1. The differences in composition are large,
with potassium, magnesium and phosphate dominating in the intracellular
space and sodium, calcium and chloride in the extracellular space (table
1). |
| Table 1: |
Composition and characteristics of the
main fluid compartments of the human body |
 |
| |
Extracellular space
|
Intracellular space |
| Parameter |
Plasma |
Interstitial fluid |
| Sodium (mmol/l) |
141 |
143 |
10 |
| Potassium (mmol/l) |
4.0 |
4.0 |
155 |
| Calcium (mmol/l) |
2.5 |
1.4 |
< 0.001 |
| Magnesium (mmol/l) |
1.0 |
0.7 |
15 |
| Chloride (mmol/l) |
103 |
115 |
8.0 |
| Phosphate (mmol/l) |
1.0 |
1.0 |
65 |
| Bicarbonate (mmol/l) |
25 |
28 |
10 |
| pH |
7.4 |
7.4 |
7.2 |
| Osmolality (mOsm/l) |
280 |
280 |
280 |
| COP (mm Hg) |
25 |
4.0 |
- |
|
 |
| Within the extracellular space the two most important compartments are
interstitial space and intravascular space with a relative size of 3 :
1 to each other. Their electrolyte composition is very similar; however,
colloid osmotic pressure (COP) is much higher in the intravascular space.
This difference is crucial in order to maintain the volume of the intravascular
space and results from the protein in plasma. Out of the 80 g/l plasma
protein about 50 g/l are albumin, but this accounts for approximately
80% of the colloid-osmotic pressure.
For the supply of tissues with oxygen and nutrients it is vital to maintain
the circulation and in this regard the maintenance of intravascular volume
is the single most important parameter.
A reduction of the circulating blood volume is called hypovolaemia and
can be the consequence of a blood or plasma loss (absolute hypovolaemia)
or a vasodilation (relative hypovalaemia). Hypovolaemia increases the
sympathetic nervous system activity and activates the renin-angiotensin-aldosterone
system. In the adult a satisfactory compensation can only be reached,
however, if the lack of volume in the circulation does not surpass
10-15% of the normal volume. Hypovolaemia above this level can no longer
be compensated for through these mechanisms alone and will result in
a sustained fall of blood pressure and increased heart rate. A reduced
cardiac preload as a consequence of diminished venous return reduces
stroke volume and hence cardiac output. The ensuing disturbance of
macro and microcirculation leads to hypoxia which itself induces endothelial
damage with activation of blood coagulation and diminishing blood flow,
especially in the microcirculation. The reduced blood flow allows rouleau
formation of the red blood cells, further deteriorating the blood flow
through the capillaries. The net result is a failure of the circulatory
system to maintain adequate organ perfusion and oxygenation, organ
failures and death.
|
| The prevention of this development is based on
early and adequate plasma volume replacement. In general terms, the following
solutions are suitable for volume replacement: |
- Isotonic electrolyte solutions, also called crystalloids (e.g. Ringer´s
solution, Hartmann´s solution or NaCl 0.9% solution)
- Colloidal volume replacement solutions containing a synthetic macromolecular
substance as active ingredient in a crystalloid solution ( e.g. dextran,
gelatine and hydroxyethyl starch solutions)
- Colloidal volume replacement solutions based on natural colloids
(e.g. human albumin and plasma protein solutions)
|
| Because of the absence of a suitable macromolecular substance, crystalloid
solutions will go into the whole of the extracellular space after infusion.
Only about one fourth to one fifth of the volume infused will stay in the
circulation, while the bulk will end up in the interstitial space. The
absence of a macromolecular substance also leads to a rapid elimination
of the crystalloid solution through kidneys, giving it a volume effect
for only approximately 20-30 min. Therefore, while crystalloid solutions
are indispensable for the correction of interstitial fluid losses, their
exclusive use for vascular volume replacement is not possible if hypovolaemia
is too severe. Excessive administration of crystalloids will induce severe
interstitial oedema and may lead to pulmonary oedema and tissue hypoxia. |
|
 |
|